Eventide Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Buy |
562,990
+37,852
| +7% | +$1.65M | 0.43% | 82 |
|
|
2025
Q1 | $14.4M | Buy |
525,138
+69,410
| +15% | +$1.9M | 0.29% | 104 |
|
|
2024
Q4 | $18.3M | Sell |
455,728
-52,174
| -10% | -$2.1M | 0.33% | 96 |
|
|
2024
Q3 | $24M | Buy |
507,902
+45,803
| +10% | +$2.17M | 0.41% | 75 |
|
|
2024
Q2 | $13.8M | Buy |
462,099
+442,325
| +2,237% | +$13.2M | 0.24% | 110 |
|
|
2024
Q1 | $795K | Buy |
+19,774
| New | +$795K | 0.01% | 154 |
|